Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Dr. Agarwal Health Care IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Financial Information of Dr. Agarwal's Health Care Limited IPO
The Revenues from operations for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 8,379.40 Million, ₹ 13,764.49 Million, ₹ 10,314.94 Million and ₹ 7,137.84 Million respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 2,284.77 Million, ₹ 4,065.55 Million, ₹ 2,838.60 Million, and ₹ 1,998.22 Million, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 395.64 Million, ₹ 950.51 Million, ₹ 1,032.30 Million, and ₹ 431.64 Million respectively. This indicates a steady growth in financial performance.
Dr. Agarwal Health Care Limited Financial Information (Restated Consolidated)
Amount in (₹ in Million)
| Period Ended | Sep 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Reserve of Surplus | 14,736.35 | 13,300.48 | 6,216.31 | 2,055.17 |
| Total Assets | 33,934.07 | 26,221.01 | 18,251.74 | 10,261.34 |
| Total Borrowings | 3,692.80 | 3,877.87 | 3,561.77 | 2,901.80 |
| Fixed Assets | 5,902.60 | 4,984.68 | 3,429.46 | 2,081.88 |
| Cash | 1,667.60 | 1,117.49 | 1,269.81 | 996.21 |
| Cash flow from operating activities | ||||
| Cash flows from investing activities | ||||
| Cash flow from financing activities | ||||
| Net Borrowing | 2,025.20 | 2,760.38 | 2,291.96 | 1,905.59 |
| Revenue | 8,379.40 | 13,764.49 | 10,314.94 | 7,137.84 |
| EBITDA | 2,284.77 | 4,065.55 | 2,838.60 | 1,998.22 |
| PAT | 395.64 | 950.51 | 1,032.30 | 431.64 |
| PAT Margin | ||||
| EPS | 1.00 | 3.13 | 4 | 1.83 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Offer, given in FINANCIAL EXPRESS.





